Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial

Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial

Background: Although many acute exacerbations of COPD (AECOPD) are triggered by non-bacterial causes, they are often treated with antibiotics. Preliminary research suggests that the Chinese herbal medicine “Shufeng Jiedu” (SFJD), may improve recovery and therefore reduce antibiotic use in patients w...

Full description

Bibliographic Details
Main Authors: Merlin L. Willcox, Xiao-Yang Hu, Tom Oliver, Kerensa Thorne, Cherish Boxall, George He, Catherine Simpson, Becci Brotherwood, Alice O’Neil, Robert Waugh, Emma Tilt, Jeanne Trill, Neville Goward, Nick Francis, Michael Thomas, Paul Little, Tom Wilkinson, Jian-Ping Liu, Gareth Griffiths, Michael Moore
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Pharmacology
Subjects:
COPD
Chinese herbal medicine
feasibility clinical trial
Shufeng Jiedu capsule
acute exacerbation of chronic obstructive pulmonary disease
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1221905/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1221905/full

Similar Items